Similar Papers

Paper Title
Journal
Date
Author
APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma.
Lei Cao ... Zhixian Wu
Aging | VOL. 12
Lei Cao, et. al.Lei Cao ... Zhixian Wu
13 Mar 2020
375 Development of thrombospondin-1 as a clinical pharmacodynamic biomarker for VT1021, a first-in-class therapeutic agent that reprograms the tumor microenvironment
Jian Chen ... Michael Cieslewicz
Journal for ImmunoTherapy of Cancer | VOL. 9
Jian Chen, et. al.Jian Chen ... Michael Cieslewicz
01 Nov 2021
EFNA3 is a prognostic biomarker for the overall survival of patients with hepatocellular carcinoma.
Peng Lin ... Hong Yang
Journal of hepatology | VOL. 77
Peng Lin, et. al.Peng Lin ... Hong Yang
01 Sep 2022
Nudix hydrolase 1 is a prognostic biomarker in hepatocellular carcinoma.
Qifeng Ou ... Longjuan Zhang
Aging | VOL. 12
Qifeng Ou, et. al.Qifeng Ou ... Longjuan Zhang
27 Apr 2020
View more papers

More From: Hepatology Research

Paper Title
Journal
Date
Author
Evaluating two rechallenge strategies of immune checkpoint inhibitors: Durvalumab plus tremelimumab in advanced hepatocellular carcinoma
Takuya Yonemoto ... Naoya Kato
Hepatology Research | VOL. -
Takuya Yonemoto, et. al.Takuya Yonemoto ... Naoya Kato
15 Jan 2025
Tumor‐infiltrating CD8+ T‐cell numbers and serum C‐reactive protein levels as a prognostic biomarker in hepatocellular carcinoma patients receiving atezolizumab plus bevacizumab
Akifumi Kuwano ... Kenta Motomura
Hepatology Research | VOL. -
Akifumi Kuwano, et. al.Akifumi Kuwano ... Kenta Motomura
08 Jan 2025
Recent advances in systemic therapies for unresectable hepatocellular carcinoma and their impact on clinical outcomes
Kyoko Oura
Hepatology Research | VOL. -
Kyoko OuraKyoko Oura
03 Jan 2025
Expression patterns of hepatic Mac2‐BP in the liver microenvironment
Tomoko Tadokoro
Hepatology Research | VOL. -
Tomoko TadokoroTomoko Tadokoro
03 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.